9-93645655-C-T
Variant summary
Our verdict is Likely benign. Variant got -6 ACMG points: 0P and 6B. BP4_ModerateBS2
The NM_005392.4(PHF2):c.326C>T(p.Pro109Leu) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00000809 in 1,607,898 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 14/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★). Another variant affecting the same amino acid position, but resulting in a different missense (i.e. P109S) has been classified as Benign.
Frequency
Consequence
NM_005392.4 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_benign. Variant got -6 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | UniProt |
---|---|---|---|---|---|---|---|
PHF2 | NM_005392.4 | c.326C>T | p.Pro109Leu | missense_variant | 4/22 | ENST00000359246.9 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|
PHF2 | ENST00000359246.9 | c.326C>T | p.Pro109Leu | missense_variant | 4/22 | 1 | NM_005392.4 | P1 | |
PHF2 | ENST00000610682.1 | c.239+9190C>T | intron_variant | 5 |
Frequencies
GnomAD3 genomes AF: 0.0000328 AC: 5AN: 152238Hom.: 0 Cov.: 34
GnomAD3 exomes AF: 0.0000202 AC: 5AN: 247440Hom.: 0 AF XY: 0.00000748 AC XY: 1AN XY: 133744
GnomAD4 exome AF: 0.00000550 AC: 8AN: 1455542Hom.: 0 Cov.: 32 AF XY: 0.00000415 AC XY: 3AN XY: 723538
GnomAD4 genome AF: 0.0000328 AC: 5AN: 152356Hom.: 0 Cov.: 34 AF XY: 0.0000403 AC XY: 3AN XY: 74496
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Apr 15, 2024 | The c.326C>T (p.P109L) alteration is located in exon 4 (coding exon 4) of the PHF2 gene. This alteration results from a C to T substitution at nucleotide position 326, causing the proline (P) at amino acid position 109 to be replaced by a leucine (L). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at